119
Participants
Start Date
September 27, 2022
Primary Completion Date
July 27, 2023
Study Completion Date
July 27, 2023
EVO101
Topical Cream
Pariser Dermatology Specialists, Norfolk
Dermatology Consulting Services, PLLC, High Point
Driven Research, LLC, Coral Gables
Lenus Research and Medical Group, Miami
Dermatologists of Southwest Ohio, Mason
The Indiana Clinical Trials Center, Plainfield
Dawes Fretzin Clinical Research Group, Indianapolis
Minnesota Clinical Study Center, New Brighton
SkinSpecialists, LLC, Omaha
Clinical Trials Institute of Northwest Arkansas, Fayetteville
Northwest AR Clinical Trials Center, PLLC, Rogers
Center for Clinical Studies, Ltd LLC, Houston
J&S Studies, Inc, College Station
DermResearch, Austin
Saguaro Dermatology, Phoenix
JDR Dermatology Research, LLC, Las Vegas
Metropolis Dermatology, Los Angeles
Dermatology Research Associate, Los Angeles
Clinical Science Institute, Santa Monica
California Dermatology & Clinical Research Institute, Encinitas
Oregon Medical Research Center, Portland
Lead Sponsor
Evommune, Inc.
INDUSTRY